Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cambrex Corporation    CBM

Delayed Quote. Delayed  - 12/02 10:02:02 pm
50.7 USD   +1.10%
11/05 CAMBREX : Earnings slide
11/04 CAMBREX : posts 3Q profit
11/04 Cambrex Reports Third Quarter 2016 Financial Results
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
49.1(c) 51.05(c) 50.1(c) 50.15(c) 50.7(c) Last
182 778 232 174 316 041 265 105 254 348 Volume
-1.90% +3.97% -1.86% +0.10% +1.10% Change
More quotes
Financials ($)
Sales 2016 487 M
EBIT 2016 123 M
Net income 2016 82,6 M
Debt 2016 -
Yield 2016 -
Sales 2017 543 M
EBIT 2017 141 M
Net income 2017 91,7 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 19,98
P/E ratio 2017 18,14
Capi. / Sales2016 3,31x
Capi. / Sales2017 2,97x
Capitalization 1 612 M
More Financials
Company
Cambrex Corp. engages in the provisio ofproducts, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics.It supplies its products and services to innovator and generic pharmaceutical companies.Its products include generic and... 
Sector
Pharmaceuticals
Calendar
02/14Earnings Release
More about the company
Surperformance© ratings of Cambrex Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on CAMBREX CORPORATION
11/05 CAMBREX : Earnings slide
11/04 CAMBREX : posts 3Q profit
11/04 CAMBREX CORP : Results of Operations and Financial Condition, Financial Statemen..
11/04 CAMBREX : Management's Discussion and Analysis of Financial Condition and Result..
11/04 Cambrex Reports Third Quarter 2016 Financial Results
11/03 CAMBREX : to Announce Third Quarter 2016 Financial Results on November 4, 2016
11/01 Cambrex to Announce Third Quarter 2016 Financial Results on November 4, 2016
10/31 CAMBREX CORP : Change in Directors or Principal Officers, Financial Statements a..
10/31 Bernhard Hampl Appointed to the Board of Directors of Cambrex Corporation
10/26 CAMBREX : Research Reports Coverage on Biotech Stocks -- Radius Health, Vitae Ph..
More news
Sector news : Pharmaceuticals - NEC
01:25aDJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
11/06 Cambrex's (CBM) CEO Steve Klosk on Q3 2016 Results - Earnings Call Transcript
11/04 Cambrex revenues up 7%; non-GAAP EPS up 18% in Q3; revises 2016 guidance
11/04 Cambrex beats by $0.06, beats on revenue
11/03 Notable earnings before Friday?s open
10/03 CAMBREX : Overblown Concerns Present Attractive Entry Opportunity Into Growing M..
Advertisement
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Technical analysis trends CAMBREX CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 48,8 $
Spread / Average Target -2,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Steven M. Klosk President, Chief Executive Officer & Director
Shlomo Yanai Non-Executive Chairman
Shawn P. Cavanagh Chief Operating Officer & Executive Vice President
Gregory P. Sargen Chief Financial Officer & Executive Vice President
Peter G. Tombros Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CAMBREX CORPORATION6.50%1 612
JOHNSON & JOHNSON8.43%303 013
PFIZER INC.-2.54%190 910
ROCHE HOLDING LTD.-17.98%189 262
NOVARTIS AG-19.07%177 818
MERCK & CO., INC.15.85%167 524
More Results